Atrium Therapeutics, Inc. (RNA)
13.32
+0.02
(+0.15%)
USD |
NASDAQ |
May 14, 12:11
Atrium Therapeutics Total Liabilities (Quarterly) : 71.66M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 338.09M |
| Intellia Therapeutics, Inc. | 137.84M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Tango Therapeutics, Inc. | 63.83M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.948M |
| Shareholders Equity (Quarterly) | -62.71M |
| Debt to Equity Ratio | -0.0586 |
| Current Ratio | 0.0391 |